Barrington Research Research Analysts Boost Earnings Estimates for Stericycle, Inc. (NASDAQ:SRCL)

Stericycle, Inc. (NASDAQ:SRCL) – Stock analysts at Barrington Research upped their Q2 2024 earnings estimates for Stericycle in a report issued on Tuesday, April 30th. Barrington Research analyst K. Steinke now anticipates that the business services provider will post earnings per share of $0.57 for the quarter, up from their prior forecast of $0.55. The consensus estimate for Stericycle’s current full-year earnings is $2.31 per share. Barrington Research also issued estimates for Stericycle’s Q3 2024 earnings at $0.59 EPS, Q4 2024 earnings at $0.62 EPS and FY2025 earnings at $2.75 EPS.

Stericycle (NASDAQ:SRCL) last released its quarterly earnings results on Thursday, April 25th. The business services provider reported $0.57 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.54 by $0.03. The business had revenue of $664.90 million during the quarter, compared to the consensus estimate of $676.42 million. Stericycle had a positive return on equity of 7.31% and a negative net margin of 0.74%. The company’s quarterly revenue was down 2.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.49 EPS.

Several other analysts also recently commented on the stock. StockNews.com downgraded shares of Stericycle from a “buy” rating to a “hold” rating in a report on Tuesday, April 2nd. Truist Financial dropped their target price on shares of Stericycle from $57.00 to $50.00 and set a “hold” rating on the stock in a research report on Monday. Wells Fargo & Company boosted their target price on Stericycle from $40.00 to $48.00 and gave the stock an “underweight” rating in a research note on Friday, March 1st. Royal Bank of Canada reaffirmed an “outperform” rating and set a $69.00 price target on shares of Stericycle in a research report on Thursday, March 7th. Finally, Robert W. Baird dropped their price target on Stericycle from $62.00 to $55.00 and set a “neutral” rating on the stock in a report on Friday, April 26th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Stericycle currently has a consensus rating of “Hold” and an average price target of $59.40.

Stericycle Trading Down 1.0 %

NASDAQ SRCL opened at $44.30 on Thursday. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 0.55. The business has a fifty day simple moving average of $51.18 and a 200 day simple moving average of $48.28. Stericycle has a 12 month low of $37.78 and a 12 month high of $57.06. The firm has a market capitalization of $4.11 billion, a P/E ratio of -201.36, a PEG ratio of 2.42 and a beta of 1.12.

Institutional Trading of Stericycle

Institutional investors have recently added to or reduced their stakes in the stock. Exchange Traded Concepts LLC increased its stake in Stericycle by 87.5% in the 3rd quarter. Exchange Traded Concepts LLC now owns 1,001 shares of the business services provider’s stock worth $45,000 after acquiring an additional 467 shares during the last quarter. Simplicity Solutions LLC bought a new position in shares of Stericycle in the third quarter worth approximately $221,000. Raymond James & Associates increased its position in shares of Stericycle by 1.0% in the third quarter. Raymond James & Associates now owns 914,453 shares of the business services provider’s stock worth $40,885,000 after purchasing an additional 8,781 shares during the last quarter. Arlington Partners LLC raised its stake in Stericycle by 34.0% in the third quarter. Arlington Partners LLC now owns 3,384 shares of the business services provider’s stock valued at $151,000 after purchasing an additional 859 shares in the last quarter. Finally, Stratos Wealth Partners LTD. lifted its position in Stericycle by 4.9% during the third quarter. Stratos Wealth Partners LTD. now owns 13,763 shares of the business services provider’s stock valued at $615,000 after purchasing an additional 640 shares during the last quarter. Hedge funds and other institutional investors own 98.82% of the company’s stock.

Stericycle Company Profile

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.